(Q51122641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Ocular Drug Delivery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Uday B Kompella

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

1 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

Handbook of experimental pharmacology

26 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

57-93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

In situ gel systems as 'smart' carriers for sustained ocular drug delivery

26 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Eye-concentrated distribution of dexamethasone carried by sugar-chain modified liposome in experimental autoimmune uveoretinitis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Influence of n-octenylsuccinate starch on in vitro permeation of sodium diclofenac across excised porcine cornea in comparison to Voltaren ophtha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Transepithelial corneal collagen cross-linking by iontophoresis of riboflavin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

High-dose subconjunctival cyclosporine a implants do not affect corneal neovascularization after high-risk keratoplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Intraocular implants for extended drug delivery: therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

A review of the complications of lacrimal occlusion with punctal and canalicular plugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Improved ocular bioavailability of indomethacin by novel ocular drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Imprinted soft contact lenses as norfloxacin delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Effect of eye pigmentation on transscleral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Iontophoretic transport of charged macromolecules across human sclera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Ophthalmic light sensitive nanocarrier systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Ocular permeability screening of dexamethasone esters through combined cellular and tissue systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Polyhydroxyethylaspartamide-based micelles for ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Biopharmaceutical considerations in topical ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Transporters/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Influence of dosage form on the intravitreal pharmacokinetics of diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Drug delivery to the retina: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Iontophoresis: a non-invasive ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

New techniques for drug delivery to the posterior eye segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

A biodegradable drug delivery system for the treatment of postoperative inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Recent perspectives in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Ophthalmic delivery of cyclosporine A by punctal plugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Liposomes as an ocular delivery system of fluconazole: in-vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Iontophoresis: from the lab to the bed side.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Management of acute glaucoma with pilocarpine-soaked hydrophilic lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Comparative study of nanosized cross-linked sodium-, linear sodium- and zinc-hyaluronate as potential ocular mucoadhesive drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Cidofovir transport in the pigmented rabbit conjunctiva

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Na(+)-dependent L-arginine transport in the pigmented rabbit conjunctiva.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Strategies for therapy of retinal diseases using systemic drug delivery: relevance of transporters at the blood-retinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

A review of progress in clinical photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Topical and systemic drug delivery to the posterior segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanotechnology-based photodynamic therapy for neovascular disease using a supramolecular nanocarrier loaded with a dendritic photosensitizer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Human retinal molecular weight exclusion limit and estimate of species variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Biotin uptake by rabbit corneal epithelial cells: role of sodium-dependent multivitamin transporter (SMVT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Intrascleral drug delivery to the eye using hollow microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

In situ gelling dorzolamide loaded chitosan nanoparticles for the treatment of glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Transport barriers in transscleral drug delivery for retinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Hydrogels in ophthalmic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Recent advances in ophthalmic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanomedicines for back of the eye drug delivery, gene delivery, and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

A passive MEMS drug delivery pump for treatment of ocular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Hydrogel containing silica shell cross-linked micelles for ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Protein transport to choroid and retina following periocular injection: theoretical and experimental study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

An effective prodrug strategy to selectively enhance ocular exposure of a cannabinoid receptor (CB1/2) agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Examination of barriers and barrier alteration in transscleral iontophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Transscleral iontophoretic and intravitreal delivery of a macromolecule: study of ocular distribution in vivo and postmortem with MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Anterior eye segment drug delivery systems: current treatments and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

A review of topically administered mini-tablets for drug delivery to the anterior segment of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

In vitro transscleral iontophoresis of high molecular weight neutral compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Tolerance of ocular iontophoresis in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Global estimates of visual impairment: 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Advances in drug delivery to the posterior segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Micellar solutions of triblock copolymer surfactants with pilocarpine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Contact lenses for antifungal ocular drug delivery: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Characterization of the novel ophthalmic drug carrier Sophisen in two of its derivatives: 3A Ofteno and Modusik-A Ofteno

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Periocular routes for retinal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Barrier analysis of periocular drug delivery to the posterior segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanotherapies for the treatment of ocular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Drug and gene delivery to the back of the eye: from bench to bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Undefined role of mucus as a barrier in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Ocular drug delivery. Pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Preparation and ocular pharmacokinetics of ganciclovir liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Design of multi-drug release coatings targeting infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Mucus as a barrier to lipophilic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Ocular and systemic pharmacokinetics of latanoprost in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Designing dendrimers for ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Mechanism of L-ascorbic acid uptake by rabbit corneal epithelial cells: evidence for the involvement of sodium-dependent vitamin C transporter 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Drug delivery to the posterior segment of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanomicellar formulations for sustained drug delivery: strategies and underlying principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Targeted lipid based drug conjugates: a novel strategy for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Transcorneal permeation in a corneal device of non-steroidal anti-inflammatory drugs in drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Nanogels for oligonucleotide delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

P-glycoprotein regulates a volume-activated chloride current in bovine non-pigmented ciliary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Sustained release of Avastin® from polysaccharides cross-linked hydrogels for ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

In situ covalently cross-linked PEG hydrogel for ocular drug delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression in corneal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

Cyclosporin nanosphere formulation for ophthalmic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F164_2016_84

21 January 2018

Identifiers

DOI

10.1007/164_2016_84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27783270%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference